Synact Pharma Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Thomas Jonassen, was filed 06 Oct 2017.
Synact Pharma: what insiders have been doing
Synact Pharma is a listed company. Its insiders report their share dealings to Finansinspektionen. Nothing new has been filed by managers of Synact Pharma in twelve months, the latest record being from 6 June 2023.
Over the whole record (from 2017), the tally stands at 3 purchases and no sales.
For comparison within the same market, see the insider buying recorded at Linc AB and Dynavox Group AB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Financial data
· cache
- 65,000 shares0OptionFI:csv-8cbfed48c61a0144e443
- 9,200 shares@ SEK 6.90100.0% of flowISIN SE0008241491FI:csv-fada1b88bd3b80ed5535Canonical exit: 1 Jan 2018 (T+90)
- 9,071 shares@ DKK 7.1054100.0% of flowISIN SE0008241491FI:csv-d3a667c09f41538f7101Canonical exit: 1 Jan 2018 (T+90)
- 7,000 shares@ SEK 6.8948100.0% of flowISIN SE0008241491FI:csv-fb23a15327ed8b95ea25Canonical exit: 1 Jan 2018 (T+90)
- 18,686 shares@ SEK 6.40100.0% of flowISIN SE0008320972FI:csv-a98142f6287dbda39e89
- 5,686 shares@ SEK 6.40100.0% of flowISIN SE0008320972FI:csv-78beda993ec52cb5f5f9
6 of 6 declarations
About Synact Pharma
Synact Pharma is a pharmaceutical company focused on developing treatments for inflammatory and autoimmune diseases. It is listed on the XSTO exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations